MIF mediates bladder pain, not inflammation, in cyclophosphamide cystitis

[1]  Iman O. Sherif,et al.  Uroprotective mechanism of quercetin against cyclophosphamide‐induced urotoxicity: Effect on oxidative stress and inflammatory markers , 2018, Journal of cellular biochemistry.

[2]  H. Ishikura,et al.  Involvement of the cystathionine-γ-lyase/Cav3.2 pathway in substance P-induced bladder pain in the mouse, a model for nonulcerative bladder pain syndrome , 2018, Neuropharmacology.

[3]  L. Leng,et al.  Macrophage migration inhibitory factor mediates protease‐activated receptor 4‐induced bladder pain through urothelial high mobility group box 1 , 2017, Physiological reports.

[4]  K. Westlund,et al.  Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4 , 2017, BMC Physiology.

[5]  E. Romero-Sandoval,et al.  Mitogen-activated protein kinase phosphatase-3 (MKP-3) in the surgical wound is necessary for the resolution of postoperative pain in mice , 2017, Journal of pain research.

[6]  J. Kim,et al.  Alterations of Macrophage Migration Inhibitory Factor Expression in the Nervous System of the Rat Cystitis Model , 2017, Urologia Internationalis.

[7]  M. Hsieh,et al.  Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-induced Hemorrhagic Cystitis. , 2017, Urology.

[8]  Zhi-wei Li,et al.  Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis. , 2016, Cancer letters.

[9]  Karin N. Westlund,et al.  Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1 , 2016, PloS one.

[10]  M. Fujita,et al.  A novel method for assessing bladder‐related pain reveals the involvement of nerve growth factor in pain associated with cyclophosphamide‐induced chronic cystitis in mice , 2016, European journal of pain.

[11]  K. Westlund,et al.  Macrophage Migration Inhibitory Factor Mediates PAR-Induced Bladder Pain , 2015, PloS one.

[12]  L. Leng,et al.  MIF intersubunit disulfide mutant antagonist supports activation of CD74 by endogenous MIF trimer at physiologic concentrations , 2013, Proceedings of the National Academy of Sciences.

[13]  K. Westlund,et al.  Orofacial neuropathic pain mouse model induced by Trigeminal Inflammatory Compression (TIC) of the infraorbital nerve , 2012, Molecular Brain.

[14]  Jessica K. Alexander,et al.  Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress , 2012, Experimental Neurology.

[15]  Jie Yang,et al.  Spinal Macrophage Migration Inhibitory Factor Is a Major Contributor to Rodent Neuropathic Pain-like Hypersensitivity , 2011, Anesthesiology.

[16]  K. Iczkowski,et al.  Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice , 2010, Neurourology and urodynamics.

[17]  J. Bernhagen,et al.  Macrophage migration inhibitory factor (MIF): a promising biomarker. , 2010, Drug news & perspectives.

[18]  Jie Yang,et al.  Spinal macrophage migration inhibitory factor contributes to the pathogenesis of inflammatory hyperalgesia in rats , 2010, PAIN.

[19]  A. Kanematsu,et al.  Voided stain on paper method for analysis of mouse urination , 2008, Neurourology and urodynamics.

[20]  J. Bernhagen,et al.  The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. , 2007, Molecular endocrinology.

[21]  L. Qiao,et al.  Region-specific changes in the phosphorylation of ERK1/2 and ERK5 in rat micturition pathways following cyclophosphamide-induced cystitis. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[22]  S. McMahon,et al.  Increased spinal cord phosphorylation of extracellular signal‐regulated kinases mediates micturition overactivity in rats with chronic bladder inflammation , 2005, The European journal of neuroscience.

[23]  K. Meyer-Siegler,et al.  Substance P induced changes in CD74 and CD44 in the rat bladder. , 2005, The Journal of urology.

[24]  J. Mogil,et al.  Characterization of cyclophosphamide cystitis, a model of visceral and referred pain, in the mouse: species and strain differences. , 2003, The Journal of urology.

[25]  K. Meyer-Siegler,et al.  Anatomical location of Macrophage Migration Inhibitory Factor in urogenital tissues, peripheral ganglia and lumbosacral spinal cord of the rat , 2003, BMC Neuroscience.

[26]  K. Andersson.  Bladder activation: afferent mechanisms. , 2002, Urology.

[27]  J. Bernhagen,et al.  Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. , 2002, Microbes and infection.

[28]  C. Buffington,et al.  In vivo models of interstitial cystitis. , 2002, The Journal of urology.

[29]  K. Meyer-Siegler.  COX-2 Specific Inhibitor, NS-398, Increases Macrophage Migration Inhibitory Factor Expression and Induces Neuroendocrine Differentiation in C4-2b Prostate Cancer Cells , 2001, Molecular medicine.

[30]  T. Hammond,et al.  Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation. , 2001, Physiological genomics.

[31]  A. Eschalier,et al.  Cyclophosphamide-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of visceral pain. , 2000, The Journal of urology.

[32]  R. Atkins,et al.  MIF Expression in the Rat Brain: Implications for Neuronal Function , 1998, Molecular medicine.

[33]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[34]  S. Sternberg,et al.  Cyclophosphamide and urinary bladder toxicity. , 1961, Cancer research.

[35]  W. Dixon,et al.  Efficient analysis of experimental observations. , 1980, Annual review of pharmacology and toxicology.